TRAW
Traws Pharma Takes Flight: Revolutionary Flu Prophylactic Poised to Soar
At a time when global health concerns continue to dominate headlines, Traws Pharma is making significant strides towards revolutionizing the way we combat influenza. The company's Q4 2025 results and business update conference call provided a thrilling glimpse into its ambitious plans for Tivoxavir marboxil, a next-generation investigational